BL02U1

Jing Zhang, Xiaoyong Jiang, Han Gao, Fei Zhang, Xin Zhang, Aiwu Zhou, Ting Xu, Haiyan Cai, Structural Basis of a Novel Agonistic Anti-OX40 Antibody. Biomolecules, 12, (2022f).

Xiaojuan Chen, Huiliang Li, Qianmeng Lin, Shuyan Dai, Sitong Yue, Lingzhi Qu, Maoyu Li, Ming Guo, Hudie Wei, Jun Li, Longying Jiang, Guangyu Xu, Yongheng Chen, Structure-based design of a dual-warhead covalent inhibitor of FGFR4. Communications Chemistry, 5, (2022g).

Rui Li, Meihua Wang, Peng Gong, Crystal structure of a pre-chemistry viral RNA-dependent RNA polymerase suggests participation of two basic residues in catalysis. Nucleic Acids Research, 50, 12389-12399(2022g).

Yanli Liu, Xiajie Yang, Mengqi Zhou, Yinxue Yang, Fangzhou Li, Xuemei Yan, Mengmeng Zhang, Zhengguo Wei, Su Qin, Jinrong Min, Structural basis for the recognition of methylated histone H3 by the Arabidopsis LHP1 chromodomain. Journal of Biological Chemistry, 298, (2022g).

Hua-Qi Wang, Shu-Bin Mou, Wen Xiao, Huan Zhou, Xu-Dong Hou, Su-Jing Wang, Qian Wang, Jiali Gao, Zhiyi Wei, Lijun Liu, Zheng Xiang, Structural Basis for the Friedel-Crafts Alkylation in Cylindrocyclophane Biosynthesis. Acs Catalysis, 12, 2108-2117(2022g).

Jing Zhang, Yan Zhang, Qinglong You, Chang Huang, Tiantian Zhang, Mingzhu Wang, Tianwei Zhang, Xiaocheng Yang, Jun Xiong, Yingfeng Li, Chao-Pei Liu, Zhuqiang Zhang, Rui-Ming Xu, Bing Zhu, Highly enriched BEND3 prevents the premature activation of bivalent genes during differentiation. Science, 375, 1053-+(2022g).

Xingchen Chen, Pengkai Sun, Yan Liu, Senlin Shen, Tengfei Ma, Jianping Ding, Structures of a constitutively active mutant of human IDH3 reveal new insights into the mechanisms of allosteric activation and the catalytic reaction. Journal of Biological Chemistry, 298, (2022h).

Ruofan Li, Michael Mor, Bingting Ma, Alex E. Clark, Joel Alter, Michal Werbner, Jamie Casey Lee, Sandra L. Leibel, Aaron F. Carlin, Moshe Dessau, Meital Gal-Tanamy, Ben A. Croker, Ye Xiang, Natalia T. Freund, Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies. Communications Biology, 5, (2022h).